1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Tomizawa, T.
Koshiba, S.
Inoue, M.
Kigawa, T.
Yokoyama, S.
RIKEN Structural Genomics/Proteomics Initiative (RSGI)
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
Solution structure of the 19th filamin domain from human Filamin-B
10.2210/pdb2di8/pdb
pdb_00002di8
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
11537.700
Filamin-B
Filamin domain
1
man
polymer
FLN-B, Beta-filamin, Actin-binding-like protein, Thyroid autoantigen, Truncated actin-binding protein, Truncated ABP, ABP-280 homolog, ABP-278, Filamin 3, Filamin homolog 1, Fh1
no
no
GSSGSSGIGDARRAKVYGRGLSEGRTFEMSDFIVDTRDAGYGGISLAVEGPSKVDIQTEDLEDGTCKVSYFPTVPGVYIV
STKFADEHVPGSPFTVKISGEGRVKSGPSSG
GSSGSSGIGDARRAKVYGRGLSEGRTFEMSDFIVDTRDAGYGGISLAVEGPSKVDIQTEDLEDGTCKVSYFPTVPGVYIV
STKFADEHVPGSPFTVKISGEGRVKSGPSSG
A
hsk003002600.1
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
Cell-free protein synthesis
FLNB
9606
Homo sapiens
Cell free synthesis
PLASMID
P050919-18
RIKEN Structural Genomics/Proteomics Initiative
RSGI
NPPSFA, National Project on Protein Structural and Functional Analyses
database_2
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2006-09-29
1
1
2008-04-30
1
2
2011-07-13
1
3
2022-03-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
Y
PDBJ
Y
PDBJ
2006-03-29
REL
REL
target function, structures with the lowest energy, structures with the least restraint violations
100
20
3D_15N-separated_NOESY
3D_13C-separated_NOESY
120mM
7.0
ambient
296
K
torsion angle dynamics, restrainted molecular dynamics
1
lowest energy
0.80mM Filamin domain U-15N,13C; 20mM d-Tris-HCl(pH 7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 10% D2O
90% H2O/10% D2O
Bruker
collection
XwinNMR
3.5
Delaglio, F.
processing
NMRPipe
20030801
Johnson, B.A.
data analysis
NMRView
5.0.4
Kobayashi, N.
data analysis
KUJIRA
0.9742
Guntert, P.
structure solution
CYANA
2.0.17
Guntert, P.
refinement
CYANA
2.0.17
800
Bruker
AVANCE
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
SER
3
n
3
SER
3
A
GLY
4
n
4
GLY
4
A
SER
5
n
5
SER
5
A
SER
6
n
6
SER
6
A
GLY
7
n
7
GLY
7
A
ILE
8
n
8
ILE
8
A
GLY
9
n
9
GLY
9
A
ASP
10
n
10
ASP
10
A
ALA
11
n
11
ALA
11
A
ARG
12
n
12
ARG
12
A
ARG
13
n
13
ARG
13
A
ALA
14
n
14
ALA
14
A
LYS
15
n
15
LYS
15
A
VAL
16
n
16
VAL
16
A
TYR
17
n
17
TYR
17
A
GLY
18
n
18
GLY
18
A
ARG
19
n
19
ARG
19
A
GLY
20
n
20
GLY
20
A
LEU
21
n
21
LEU
21
A
SER
22
n
22
SER
22
A
GLU
23
n
23
GLU
23
A
GLY
24
n
24
GLY
24
A
ARG
25
n
25
ARG
25
A
THR
26
n
26
THR
26
A
PHE
27
n
27
PHE
27
A
GLU
28
n
28
GLU
28
A
MET
29
n
29
MET
29
A
SER
30
n
30
SER
30
A
ASP
31
n
31
ASP
31
A
PHE
32
n
32
PHE
32
A
ILE
33
n
33
ILE
33
A
VAL
34
n
34
VAL
34
A
ASP
35
n
35
ASP
35
A
THR
36
n
36
THR
36
A
ARG
37
n
37
ARG
37
A
ASP
38
n
38
ASP
38
A
ALA
39
n
39
ALA
39
A
GLY
40
n
40
GLY
40
A
TYR
41
n
41
TYR
41
A
GLY
42
n
42
GLY
42
A
GLY
43
n
43
GLY
43
A
ILE
44
n
44
ILE
44
A
SER
45
n
45
SER
45
A
LEU
46
n
46
LEU
46
A
ALA
47
n
47
ALA
47
A
VAL
48
n
48
VAL
48
A
GLU
49
n
49
GLU
49
A
GLY
50
n
50
GLY
50
A
PRO
51
n
51
PRO
51
A
SER
52
n
52
SER
52
A
LYS
53
n
53
LYS
53
A
VAL
54
n
54
VAL
54
A
ASP
55
n
55
ASP
55
A
ILE
56
n
56
ILE
56
A
GLN
57
n
57
GLN
57
A
THR
58
n
58
THR
58
A
GLU
59
n
59
GLU
59
A
ASP
60
n
60
ASP
60
A
LEU
61
n
61
LEU
61
A
GLU
62
n
62
GLU
62
A
ASP
63
n
63
ASP
63
A
GLY
64
n
64
GLY
64
A
THR
65
n
65
THR
65
A
CYS
66
n
66
CYS
66
A
LYS
67
n
67
LYS
67
A
VAL
68
n
68
VAL
68
A
SER
69
n
69
SER
69
A
TYR
70
n
70
TYR
70
A
PHE
71
n
71
PHE
71
A
PRO
72
n
72
PRO
72
A
THR
73
n
73
THR
73
A
VAL
74
n
74
VAL
74
A
PRO
75
n
75
PRO
75
A
GLY
76
n
76
GLY
76
A
VAL
77
n
77
VAL
77
A
TYR
78
n
78
TYR
78
A
ILE
79
n
79
ILE
79
A
VAL
80
n
80
VAL
80
A
SER
81
n
81
SER
81
A
THR
82
n
82
THR
82
A
LYS
83
n
83
LYS
83
A
PHE
84
n
84
PHE
84
A
ALA
85
n
85
ALA
85
A
ASP
86
n
86
ASP
86
A
GLU
87
n
87
GLU
87
A
HIS
88
n
88
HIS
88
A
VAL
89
n
89
VAL
89
A
PRO
90
n
90
PRO
90
A
GLY
91
n
91
GLY
91
A
SER
92
n
92
SER
92
A
PRO
93
n
93
PRO
93
A
PHE
94
n
94
PHE
94
A
THR
95
n
95
THR
95
A
VAL
96
n
96
VAL
96
A
LYS
97
n
97
LYS
97
A
ILE
98
n
98
ILE
98
A
SER
99
n
99
SER
99
A
GLY
100
n
100
GLY
100
A
GLU
101
n
101
GLU
101
A
GLY
102
n
102
GLY
102
A
ARG
103
n
103
ARG
103
A
VAL
104
n
104
VAL
104
A
LYS
105
n
105
LYS
105
A
SER
106
n
106
SER
106
A
GLY
107
n
107
GLY
107
A
PRO
108
n
108
PRO
108
A
SER
109
n
109
SER
109
A
SER
110
n
110
SER
110
A
GLY
111
n
111
GLY
111
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
TYR
17
A
N
TYR
17
A
O
ILE
33
A
O
ILE
33
A
N
SER
30
A
N
SER
30
A
O
TYR
70
A
O
TYR
70
A
O
SER
69
A
O
SER
69
A
N
GLN
57
A
N
GLN
57
A
N
GLY
24
A
N
GLY
24
A
O
SER
99
A
O
SER
99
A
O
PHE
94
A
O
PHE
94
A
N
VAL
80
A
N
VAL
80
A
O
SER
81
A
O
SER
81
A
N
ALA
47
A
N
ALA
47
1
A
SER
5
-38.86
147.39
1
A
VAL
89
-48.30
156.88
1
A
PRO
90
-69.77
83.29
1
A
GLU
101
-54.53
173.84
1
A
ARG
103
-42.53
153.42
2
A
SER
3
-41.54
108.55
2
A
SER
52
-170.02
138.90
2
A
PRO
90
-69.78
81.12
3
A
ALA
85
71.99
45.84
3
A
VAL
89
-47.20
156.55
3
A
PRO
90
-69.76
81.85
3
A
SER
106
-40.42
108.16
4
A
SER
22
-97.00
-64.54
4
A
VAL
89
-47.73
156.58
4
A
PRO
90
-69.79
83.00
4
A
GLU
101
-172.38
113.87
4
A
VAL
104
-57.60
109.41
4
A
LYS
105
-35.17
127.22
4
A
SER
109
34.79
45.75
5
A
PRO
51
-69.76
1.79
5
A
VAL
89
-48.03
157.18
5
A
PRO
90
-69.75
82.97
5
A
GLU
101
-35.83
143.11
6
A
SER
2
-37.48
106.78
6
A
SER
22
-104.51
-66.42
6
A
VAL
89
-47.43
157.27
6
A
PRO
90
-69.80
80.57
6
A
PRO
108
-69.77
90.83
7
A
ALA
47
-166.77
118.89
7
A
VAL
89
-49.28
157.25
7
A
PRO
90
-69.75
83.84
7
A
VAL
104
-42.15
152.66
8
A
SER
5
-123.39
-55.15
8
A
SER
6
-38.81
157.44
8
A
SER
22
-101.93
-62.44
8
A
PRO
51
-69.79
1.39
8
A
VAL
89
-45.41
156.50
8
A
PRO
90
-69.75
79.93
8
A
VAL
104
-44.19
105.99
8
A
SER
110
70.55
42.12
9
A
SER
22
-110.08
-73.57
9
A
PRO
90
-69.79
85.94
10
A
PRO
51
-69.71
1.28
10
A
VAL
89
-46.22
156.09
10
A
PRO
90
-69.77
84.57
10
A
GLU
101
-37.45
94.95
10
A
ARG
103
-49.47
106.64
11
A
SER
3
-64.87
80.03
11
A
SER
22
-108.53
-61.10
11
A
VAL
89
-45.93
156.40
11
A
PRO
90
-69.75
80.29
11
A
SER
99
-72.70
-71.78
11
A
VAL
104
-45.51
151.16
11
A
SER
106
-91.42
-64.90
12
A
SER
22
-94.57
-69.46
12
A
GLU
87
-160.03
114.96
12
A
PRO
90
-69.77
87.16
12
A
ARG
103
-170.37
111.02
12
A
VAL
104
-46.20
155.53
12
A
SER
109
-36.62
120.45
12
A
SER
110
-64.61
95.31
13
A
SER
6
-100.96
55.49
13
A
SER
22
-94.70
-63.79
13
A
PHE
27
45.47
29.58
13
A
VAL
89
-46.71
156.32
13
A
PRO
90
-69.76
86.38
13
A
GLU
101
-57.17
89.88
13
A
SER
109
-37.79
111.99
14
A
ALA
47
-164.58
108.18
14
A
ASP
55
-49.61
152.38
14
A
VAL
89
-44.99
155.80
14
A
PRO
90
-69.81
86.30
14
A
ARG
103
-43.93
168.00
14
A
VAL
104
-44.48
101.66
14
A
SER
106
-69.14
81.14
14
A
SER
109
-129.46
-56.86
14
A
SER
110
-69.62
98.44
15
A
SER
22
-103.34
-62.37
15
A
MET
29
-55.82
109.73
15
A
ALA
47
-160.18
111.55
15
A
ALA
85
70.03
43.29
15
A
VAL
89
-47.43
156.18
15
A
PRO
90
-69.73
85.24
15
A
SER
99
-57.67
-72.43
15
A
LYS
105
-41.14
160.25
16
A
SER
5
-57.12
171.52
16
A
SER
22
-99.73
-60.77
16
A
PRO
51
-69.85
1.86
16
A
THR
73
-130.85
-42.36
16
A
VAL
89
-44.24
156.03
16
A
PRO
90
-69.79
88.59
16
A
PRO
93
-69.75
-179.33
16
A
GLU
101
-129.30
-55.54
16
A
PRO
108
-69.79
2.83
17
A
ALA
47
-161.47
118.69
17
A
VAL
89
-46.24
156.26
17
A
PRO
90
-69.74
82.82
17
A
ARG
103
-162.67
106.71
17
A
SER
106
-168.46
111.54
17
A
PRO
108
-69.79
2.73
18
A
SER
5
-42.85
164.82
18
A
SER
6
39.59
51.59
18
A
SER
22
-100.25
-66.84
18
A
VAL
89
-45.31
155.99
18
A
PRO
90
-69.74
85.06
18
A
VAL
104
-44.37
151.29
19
A
VAL
89
-46.76
156.23
19
A
PRO
90
-69.82
89.13
19
A
GLU
101
-114.27
57.60
20
A
SER
6
-44.07
164.16
20
A
ALA
47
-162.12
108.38
20
A
ASP
55
-49.44
152.38
20
A
VAL
89
-44.44
156.00
20
A
PRO
90
-69.77
87.86
20
A
GLU
101
-37.28
107.16
20
A
ARG
103
-36.34
123.79
20
A
VAL
104
-46.22
151.86
Solution structure of the 19th filamin domain from human Filamin-B
1
N
N
A
ASP
10
A
ASP
10
HELX_P
A
ALA
14
A
ALA
14
5
1
5
STRUCTURAL PROTEIN
beta-sandwich, immunoglobulin-like fold, filamin domain, Structural Genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, STRUCTURAL PROTEIN
A
SER
92
A
SER
92
1
A
PRO
93
A
PRO
93
-0.11
A
SER
92
A
SER
92
2
A
PRO
93
A
PRO
93
0.00
A
SER
92
A
SER
92
3
A
PRO
93
A
PRO
93
-0.08
A
SER
92
A
SER
92
4
A
PRO
93
A
PRO
93
0.08
A
SER
92
A
SER
92
5
A
PRO
93
A
PRO
93
0.02
A
SER
92
A
SER
92
6
A
PRO
93
A
PRO
93
0.00
A
SER
92
A
SER
92
7
A
PRO
93
A
PRO
93
-0.06
A
SER
92
A
SER
92
8
A
PRO
93
A
PRO
93
-0.12
A
SER
92
A
SER
92
9
A
PRO
93
A
PRO
93
-0.10
A
SER
92
A
SER
92
10
A
PRO
93
A
PRO
93
-0.05
A
SER
92
A
SER
92
11
A
PRO
93
A
PRO
93
-0.08
A
SER
92
A
SER
92
12
A
PRO
93
A
PRO
93
0.03
A
SER
92
A
SER
92
13
A
PRO
93
A
PRO
93
-0.05
A
SER
92
A
SER
92
14
A
PRO
93
A
PRO
93
-0.09
A
SER
92
A
SER
92
15
A
PRO
93
A
PRO
93
0.01
A
SER
92
A
SER
92
16
A
PRO
93
A
PRO
93
-0.09
A
SER
92
A
SER
92
17
A
PRO
93
A
PRO
93
-0.04
A
SER
92
A
SER
92
18
A
PRO
93
A
PRO
93
0.04
A
SER
92
A
SER
92
19
A
PRO
93
A
PRO
93
-0.08
A
SER
92
A
SER
92
20
A
PRO
93
A
PRO
93
-0.01
FLNB_HUMAN
UNP
1
1999
O75369
1999
2096
2DI8
8
105
O75369
A
1
8
105
1
cloning artifact
GLY
1
2DI8
A
O75369
UNP
1
1
cloning artifact
SER
2
2DI8
A
O75369
UNP
2
1
cloning artifact
SER
3
2DI8
A
O75369
UNP
3
1
cloning artifact
GLY
4
2DI8
A
O75369
UNP
4
1
cloning artifact
SER
5
2DI8
A
O75369
UNP
5
1
cloning artifact
SER
6
2DI8
A
O75369
UNP
6
1
cloning artifact
GLY
7
2DI8
A
O75369
UNP
7
1
cloning artifact
SER
106
2DI8
A
O75369
UNP
106
1
cloning artifact
GLY
107
2DI8
A
O75369
UNP
107
1
cloning artifact
PRO
108
2DI8
A
O75369
UNP
108
1
cloning artifact
SER
109
2DI8
A
O75369
UNP
109
1
cloning artifact
SER
110
2DI8
A
O75369
UNP
110
1
cloning artifact
GLY
111
2DI8
A
O75369
UNP
111
4
4
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
A
LYS
15
A
LYS
15
A
GLY
18
A
GLY
18
A
SER
30
A
SER
30
A
ASP
35
A
ASP
35
A
CYS
66
A
CYS
66
A
TYR
70
A
TYR
70
A
ILE
56
A
ILE
56
A
GLN
57
A
GLN
57
A
GLU
23
A
GLU
23
A
ARG
25
A
ARG
25
A
PHE
94
A
PHE
94
A
SER
99
A
SER
99
A
VAL
77
A
VAL
77
A
PHE
84
A
PHE
84
A
ILE
44
A
ILE
44
A
GLU
49
A
GLU
49